Satoru Iwamoto
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.
Journal: Liver cancer
Published: February 06, 2026
Thoracoscopic biopsy should be considered for pulmonary nodules with the halo sign during immunotherapy for hepatocellular carcinoma.
Journal: Clinical journal of gastroenterology
Published: December 16, 2025
Vonoprazan-Containing Triple Therapy Based on Clarithromycin Susceptibility May Be Definitive Treatment Strategy for Eradication of Helicobacter pylori.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: December 12, 2025
Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 20, 2025
First report of metabolic complete response in hepatic sarcomatoid carcinoma achieved with carbon-ion radiotherapy.
Journal: Clinical journal of gastroenterology
Published: February 25, 2025
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
Journal: Journal of gastroenterology
Published: October 21, 2024
Acute-onset Type 1 Diabetes Mellitus and Pancreatic Atrophy Caused by an Immune Checkpoint Inhibitor.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 19, 2024
An open-label, randomized, controlled trial on the benefit of β-hydroxy-β-methyl butyrate, l-arginine, l-glutamine combination beverages and locomotion training as supportive care for the treatment of unresectable hepatocellular carcinoma using lenvatinib: A pilot study (HELLO study).
Journal: Clinical nutrition ESPEN
Published: June 29, 2024
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
Journal: Journal of gastroenterology
Published: June 05, 2024
Analysis of prognostic factors in patients with self-expandable metallic stents for treatment of malignant gastric outlet obstruction.
Journal: Scandinavian journal of gastroenterology
Published: February 02, 2023
Selection of regimens for patients with hepatitis C virus genotype/serotype discrepancy.
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: July 07, 2017
Last Updated: 09/26/2026